2011 ACCF/AHA/HRS Focused Updates Incorporated into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation
2011 ACCF/AHA/HRS Focused Updates Incorporated into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation
复制标题
DOI：
10.1161/cir.0b013e318214876d
复制
发表时间：
2011-03-15
期刊：
影响因子：
37.8
通讯作者：
Wann, L. Samuel
中科院分区：
文献类型：
--
作者：
Fuster, Valentin;Ryden, Lars E.;Wann, L. Samuel
1.1.委员会组织和证据审查（已更新）有关新的或更新的文本，请查看2011年重点更新和达比加群2011年更新。支持未作修改的建议的案文尚未更新。心房颤动（AF）是最常见的持续性心律失常，患病率随年龄增长而增加。AF通常与结构性心脏病相关，尽管相当大比例的AF患者没有可检测到的心脏病。与AF相关的血流动力学损害和血栓栓塞事件导致显著的发病率、死亡率和成本。因此，美国心脏病学会（ACC）、美国心脏协会（AHA）和欧洲心脏病学会（ESC）成立了一个委员会，以制定这种频繁和复杂心律失常的最佳管理指南。该委员会由代表ACC、AHA和ESC以及欧洲心律协会（EHRA）和心律协会（HRS）的成员组成。本文件由ACC提名的2名官方评审员、AHA提名的2名官方评审员和ESC提名的2名官方评审员以及ACCF临床电生理学委员会、AHA ECG和心律失常委员会、AHA卒中评审委员会、EHRA、HRS和编写委员会提名的众多其他内容评审员进行了评审。该文件由ACC、AHA和ESC的理事机构批准出版，并由EHRA和HRS正式认可。
1.1. Organization of Committee and Evidence Review (UPDATED) For new or updated text, view the 2011 Focused Update and the 2011 Update on Dabigatran. Text supporting unchanged recommendations has not been updated. Atrial fibrillation (AF) is the most common sustained cardiac rhythm disturbance, increasing in prevalence with age. AF is often associated with structural heart disease, although a substantial proportion of patients with AF have no detectable heart disease. Hemodynamic impairment and thromboembolic events related to AF result in significant morbidity, mortality, and cost. Accordingly, the American College of Cardiology (ACC), the American Heart Association (AHA), and the European Society of Cardiology (ESC) created a committee to establish guidelines for optimum management of this frequent and complex arrhythmia. The committee was composed of members representing the ACC, AHA, and ESC, as well as the European Heart RhythmAssociation (EHRA) and the Heart Rhythm Society (HRS). This document was reviewed by 2 official reviewers nominated by the ACC, 2 official reviewers nominated by the AHA, and 2 official reviewers nominated by the ESC, as well as by the ACCF Clinical Electrophysiology Committee, the AHA ECG and Arrhythmias Committee, the AHA Stroke Review Committee, EHRA, HRS, and numerous additional content reviewers nominated by the writing committee. The document was approved for publication by the governing bodies of the ACC, AHA, and ESC and officially endorsed by the EHRA and the HRS.